You are on page 1of 6

DAFTAR PUSTAKA

Abdoerrachman, M. H. (2007). Ilmu Kesehatan Anak. Edisi 4. Bagian Ilmu Kesehatan Anak
Fakultas Kedokteran Universitas Indonesia. Jakarta. Hlm : 444-450

Alavian, S.M., Tabatabaei S.V. 2010. Treatment of Chronic Hepatitis C in Polytransfused


Thalassaemic Patients: a Meta Analysis. J Viral Hepat. Vol 17. Page : 236-244

Aminizadeh, E., Alavian S.M., Akbari S.A., Ebrahimi D.N., Behnava B. 2016. Safety and Efficacy
of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection
in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials.
Hepat Mon . Vol 16 Page : 528-537

Angelucci E, Barosi G, Camashella C, Capellini MD, Cazzola M, Galanello R, et al. 2008. Italian
Society of Hematology Practice Guidelines for the Management of Iron Overload in
Thalassemia Major and Related Disorder. Haematologica. Vol 93. No 5. Page : 741-752

Ansari, S.H., Shamsi T.S., Khan M.T., et al. 2012. Seropositivity of hepatitis C, hepatitis B and
HIV in Chronically Transfused Β-Thalassaemia Major Patients. J Coll Physicians Surg
Pak. Vol 22. Page : 610-611

Arief, S. 2012. Hepatitis Virus. Dalam: M. Juffrie, S. S. Y. Soenarto, H. Oswari & S. Arief. Buku
Ajar Gastroenterologi-Hepatologi. Jakarta: Badan Penerbit IDAI. Hlm : 296-305

Ataei, B., Hashemipour M., Kassaian N., Hassannejad R., Nokhodian Z., Adibi P. 2012.
Prevalence of Anti HCV Infection in Patients with Betathalassemia in Isfahan-iran. Int J
Prev Med. Vol 3. No 1. Page : 118–123

Atmakusumah, T.D., Setyaningsih, I. 2009. Dasar-Dasar Talasemia: Salah Satu Jenis


Hemoglobinopati. Dalam: Sudoyo, A.W., Setiyohadi, B., Alwi, I.,Simadibrata, M., Setiati,
S. Buku Ajar Ilmu Penyakit Dalam. Edisi V. Jakarta: Interna Publishing

Atwa, Z.T., Wafaa Y.A.W. 2017. Transfusion Transmitted Infections in Frequently Transfused
Thalassemic Children Living in Fayoum Governorate, Egypt: Current Prevalence and
Risk Factors. Journal of Infection and Public Health. Vol 10. Page : 870–874
Bastani, M.N., Bokharaei-Salim F., Keyvani H., Esghaei M., Monavari S.H., Ebrahimi M., et al.
2016. Prevalence of Occult Hepatitis C Virus Infection in Iranian Patients with Beta
Thalassemia Major. Arch Virol. Vol 161. No 7. Page : 1899–906

Borgna-Pignatti, C. et al. 2004. Survival and Complications in Patients with Talasemia Major
Treated with Transfusion and Deferoxamine. Haematologica, Volume 89. Page : 1187-
1193.

Brooks, G.F., Butel, J.S., Morse, S.A. 2008. Mikrobiologi Kedokteran Jawetz, Melnick,&
Adelberg. 23th ed. Jakarta: Penerbit Buku Kedokteran EGC.

Centers for Disease Control and Prevention. 2014. Hepatitis C FAQs for the Public. National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention CDC.
http://www.cdc.gov/hepatitis/c/cfaq.html Diakses 8 Februari 2018

David, A., Xavier A., Dominique C.F., Isabelle H., Armand G., Robert G., et al. 2009. Treatment
of Chronic Hepatits C in Sickle Cell Disease and Thalassaemic Patients with Interferon
And Ribavirin. Eur J Gastroenterol Hepatol. Vol 21. Page : 726-729

DeBaun M.R., Frei-Jones M., Vichinsky E. 2011. Talasemia Syndrome. In : Kliegman RM,
Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatric. 19th Edition.
Philadelphia. PA : Sounders Elsevier. Page : 456 – 459

Diadora. 2013. Proporsi Infeksi HBV, HCV, dan HIV pada Pasien Talasemia-ß Mayor di RSUP
Haji Adam Malik Medan Periode Januari 2009 - Juli 2013. Skripsi. Fakultas Kedokteran
Universitas Sumatera Utara, Medan

Dorland, W. N. 2009. Kamus Saku Kedokteran Dorland. 28th ed. Jakarta: Elsevier.

European Association for the Study Of Liver (EASL). 2014. Management Of Hepatitis C Virus
Infection. J Of Hep.

Franchini M., Targher G., Capra F., Montagnana M., Lippi G. 2008. The effect of iron depletion
on chronic hepatitis C virus infection. Hepatol Int. Vol 2. No 3. Page :335-40
Galanello, R., Cao, A. 2011. Alpha-Thalassemia. Genetics in Medicine. Vol 13. No 2. Page : 83-
88

Sudoyo, A.W., Setiyohadi, B., Simadibrata, K. M., 2009. Buku Ajar Ilmu Penyakit Dalam Jilid 1
Edisi V. Jakarta: Interna Publishing Pusat Penerbitan Ilmu Penyakit Dalam. Page : 662-
667

Herdata, H.N. 2008. Talasemia.


http://ebookfkunsyiah.wordpress.com/category/hematoonkologi/talasemia/ Diakses 8 Februari
2018

Hoffbrand, A.V., Taher A., Capellini M.D. 2010. How I Treat Transfusional Overload. Blood. Vol
120. No 18. Page : 3657-3669

Jafroodi, M., Ali D.K., Zahra M.A., Ali A.P.,Azade H. 2015. Trend in Prevalence of Hepatitis C
Virus Infection among ß-thalassemia Major Patients: 10 Years of Experience in Iran.
International Journal of Preventive Medicine. Vol 6. No 89. Page : 1-5

Jain, R., et al. 2012. A Prospective Study for Prevalence and/or Development of Transfusion
Transmitted Infections in Multiply Transfused Talasemia Major Patients. Asian Journal
of Tranfusion Science, Vol 6. No 2. Page : 151-154

Kalantari, H., Rad N. 2010. Efficacy of Interferon Alpha-2b with or without Ribavirin in
Thalassemia Major Patients with Chronic Hepatitis C Virus Infection: A Randomized,
Double Bind, Controlled, Parallel Group Trial. J Res Med Sci.Vol 15. Page 310-316

Khodabandehloo, M, Roshani D., Sayehmiri K. 2013. Prevalence and Trend of Hepatitis C Virus
Infection among Blood Donors in Iran: A systematic Review and Meta-analysis. J Res
Med Sci. Vol 18. No 8. Page : 674–682

Made, A., Ariawati K. 2011. Profil Pertumbuhan, Hemoglobin Pretranfusi, Kadar Feritin, dan Usia
Tulang Anak Pada Talasemia Mayor. Sari Pediatri, Vol 13. No 4

Mahmoud, R.A., Abdel-Azeem M.E.M., Ashraf K. 2016. Seroprevalence of Hepatitis C, Hepatitis


B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused
Thalassemic Children in Upper Egypt. Advances in Hematology. Vol 2016. Page : 1 - 7
Mihardja, L., Dewi, M., Lestari, C.S.W., Handayani, S., Rofiq, A., Setiawati, V. et al. 2012.
Laporan Riskesdas Tahun 2007 Bidang Biomedis. Jakarta: Kementerian Kesehatan RI
2012. Hlm : 1-75.

Mitsuyoshi H., Yasui K., Yamaguchi K., Minami M., Okanoue T., Itoh Y. 2013. Pathogenic Role
of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic
Hepatitis C. Int J Hepatol. Page : 686-689

Mukherjee, K., Debojyoti B.,Goutam C. 2017. Prevalence of Hepatitis B and Hepatitis C Virus
Infection in Repeatedly Transfused Thalassemics in a Tertiary Care Hospital in Eastern
India. International Journal of Research in Medical Sciences. Vol 5. No. 10. Page : 4558-
4562

Old, J. 2013. Hemoglobinopathies and Thalassemias. In: Rimoin, D.L., Pyeritz, R.E., Korf, I.
Emery and Rimoin’s Essential Medical Genetics. Elsevier.

Perhimpunan Peneliti Hati Indonesia. 2014. Konsensus Nasional Penatalaksanaan Hepatitis C di


Indonesia. Jakarta: Penerbit PPHI.

Permono, B., Ugrasena I.D.G. 2010. Buku Ajar Hematologi – Onkologi Anak. Jakarta: Badan
Penerbit Ikatan Dokter Anak Indonesia

Priyantiningsih R.D. 2010. Pengaruh Deferasirox Terhadap Kadar T4 dan TSH pada Penderita β-
Talasemia Mayor dengan Ferritin yang Tinggi. Thesis. Fakultas Kedokteran. Universitas
Diponegoro, Semarang.

Quratul-Ain, L.A., M. Hassan, S. M. Rana, and F. Jabeen. 2011. Prevalence of β-Thalassemic


Patients Associated with Consanguinity and anti-HCV-Antibody Positivity—a Cross
Sectional Study. Pakistan Journal of Zoology. Vol 43. No 1. Page : 29-36.

Rafiei, A, Darzyani A.M., Taheri S., Haghshenas M.R., Hosseinian A., Makhlough A. 2013.
Genetic Diversity of HCV among Various High Risk Populations (IDAs, Thalassemia,
Hemophilia, HD Patients) in Iran. Asian Pac J Trop Med. Vol 6. No 7. Page : 556–560
Ricerca, B.M., Girolamo, A.D., Rund, D. 2009. Infections in Talasemia and Hemoglobinopathies:
Focus on Therapy-Related Complications. http://www.mjhid.org/article/view/5229/html.
Diakses 8 Februari 2018

Rund, D., Rachmileweitz, E. 2005. β-Thalassemia. N Engl J Med. Vol 353. Page : 1135-1146

Sadia, S., Syed M.I., Muniza S., Syed M.H.Z. 2016. Current Trends of Seroprevalence of
Transfusion Transmitted Infections In Pakistani β-Thalassaemic Patients. Malaysian J
Pathol. Vol 38. No 3. Page : 251 – 255

Sajjad, S.F., Waquaruddin A., Syed S.H.J., Mohammad A., Syed E.A. 2017. Treatment of Chronic
Hepatitis C in Thalassemia Major Patients. J Pak Med Assoc. Vol 67. No 6. Page : 926-
928

Sanityoso, A., 2009. Hepatitis Virus Akut. Dalam: Buku Ajar Ilmu Penyakit Dalam. Jakarta:
Interna Publishing. Page : 644-661

Sayani, F. et al. 2012. Guidelines for the Clinical Care of Patients with Talasemia in Canada.
North York: Talasemia Foundation of Canada.

Sastroasmoro, Sudigdo, Sofyan I. 2014. Pemilihan Subyek Penelitian. Dalam: Dasar-Dasar


Metodologi Penilitian Klinis. Jakarta: Sagung Seto.

Schrier, S.L. 2002. Pathophysiology of Talasemia. Current Opinion in Hematology, Vol 9. No 2.


Page : 123–126

Shah, N., Mishra A., Chauhan D., Vora C., Shah N.R. 2010. Study on Effectiveness of Transfusion
Program in Thalassemia Major Patients Receiving Multiple Blood Transfusions at a
Transfusion Centre in Western India. Asian J Transfus Science. Vol 2. Page : 94–98

Sugiyono. 2006. Metode Penelitian Kuantitatif, Kualitatif dan R & D. Bandung: Alfabeta.

Syarifurnama, D. 2009. Karakteristik Penderita Talasemia yang Dirawat Inap di Rumah Sakit
Umum Pusat Haji Adam Malik Medan Tahun 2006 - 2008. Skripsi. Fakultas Kesehatan
Masyarakat Universitas Sumatera Utara, Medan
Tabatabaei, S.V., Alavian S.M., Keshvari M., Behnava B., Miri S.M., Elizee P.K., et al. 2012.
Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major
Patients; New Indications for Combination Therapy. Hepat Mon. Vol 12. Page 372-381

Tamam, et al. 2010. Hubungan antara Tipe Mutasi Gen Globin dan Manifestasi Klinis Penderita
talasemia. Jurnal Kedokteran Brawijaya. Vol 26.

Talasemia International Federation. 2014. Guidelines for the Management of


Transfusion Dependent Thalassaemia (TDT) 3rd edition.

World Health Organization. 2016. Guidelines for the Screening, Care and Treatment of Persons
With Hepatitis C Infection. WHO Library Cataloguing-in- Publication Data.

World Health Organization. 2017. Global Hepatitis Report 2017. Geneva: World Health
Organization. Licence: CC BY-NC-SA 3.0 IGO.

Walker, E., Walker S., 2000. Effects of Iron Overload on Immune System. Ann Clin Lab Sci. Vol
30. No 4. Page : 354-365

Wiener, E., Allen D., Porter R., Wickramashinge, S., 1999. Role of Fcgamma RI (CD64) in
Erythrocyte Elimination and Its Up-Regulation in Thalassaemia. British Journal of
Haematology. Vol 106. No 4. Page : 923-930

Yousefi, M, Mohammad M.D., Mehrnoosh E., Azizallah D. 2017. The Prevalence of Hepatitis C
Virus Infection in Patients with Thalassemia in Zabol City of Iran. Int J Infect. Vol 4. No
1. Page : 1-3